retatrutide phase 2 results RETATRUTIDE: The “Next Big Fat Loss Peptide” — But Here's What You NEED To Know 👀💉 is one of the newest peptides being talked about in the fitness and weight loss retatrutide phase 2 diabetes trial

In 2023, the Indian GLP-1 market was valued at USD 105.7 million and is projected to grow at a CAGR of 27.5%, reaching approximately USD 578.9 million by 2030

Vegans obtain less carnitine from their diets, and for many people, its not a problem because their bodies naturally produce enough

No matter what the individual is able to do behaviorally or psychologically, they couldn't fight that

The Phase 2 dose-finding trial (N=338), published in the New England Journal of Medicine in 2023 (DOI: 10.1056/NEJMoa2301972), randomized participants with obesity (BMI 30-50) to retatrutide at doses ranging from 0.5mg to 12mg weekly or placebo over 48 weeks